Journal of Oceanology and Limnology   2019, Vol. 37 issue(3): 790-805     PDF
Institute of Oceanology, Chinese Academy of Sciences

Article Information

A mini-review on the microbial continuum: consideration of a link between judicious consumption of a varied diet of macroalgae and human health and nutrition
Journal of Oceanology and Limnology, 37(3): 790-805

Article History

Received Apr. 18, 2018
accepted in principle Aug. 8, 2018
accepted for publication Nov. 2, 2018
A mini-review on the microbial continuum: consideration of a link between judicious consumption of a varied diet of macroalgae and human health and nutrition
1 Acadian Seaplants Limited, James S. Craigie Research Center, Cornwallis B0S 1A0, N. S. Canada;
2 University of Copenhagen, Department of Food Science and Taste for Life, Design and Consumer Behavior, Nordic Food Lab, Rolighedsvej 26, Frederiksberg DK-1958, Denmark;
3 Verschuren Centre for Sustainability in Energy and the Environment, Cape Breton University, Sydney, Nova Scotia B1P 6L2, Canada
Abstract: As the primordial, prokaryotic inhabitants on Earth, microbial entities were responsible for significant influences on the pathways taken in the development of life as we know it. The manifestation of numerous pathologies in humans is considered to be intrinsically associated with microbial dysbiosis in the gut (i.e. a poorly balanced microbiota). Such adverse health conditions include obesity, chronic fatigue syndrome, cancer, cardiovascular issues, neurological disorders, colitis, irritable bowel syndrome (IBS), and rheumatoid arthritis. Endosymbiotic events at the single cell level took place billions of years ago, eventually leading to eukaryotes, photosynthesis, and multicellularity. Macroalgae (seaweeds) were amongst the first organisms to develop these characteristics. Microbes and macroalgae interacted in a pattern of co-evolution, a process that applies to most, if not all living organisms. It is recognized that the normal human microbiome consists of over a trillion microorganisms, including about 2 000 commensal bacterial species typically stationed in the gut. Many of these live in the colon, where they function in the digestion of foods, releasing bio-available nutrients, bioactive molecules, and various metabolites. They mediate communication signals between the gut and the brain, and promote the normal development of immune function, metabolic activities, behaviour, and neurological stability. As very early humans foraged for food, some would have benefitted from coastal diets, rich in seaweeds and associated microbes. Such diets would have consistently provided all the nutrients essential for survival and growth, and as such, could have conveyed competitive advantages and contributed to enhanced cognitive sophistication. This mini-review article highlights studies regarding the health benefits of dietary fibres and the production of short chain fatty acids (SCFA). Insights are offered regarding the positive effects the inclusion of macroalgae into the standard, Western diet can deliver in terms of providing appropriate fodder for those microbial populations deemed beneficial to human health and wellness.
Keywords: microbiota    macroalgae    fibre    short chain fatty acids (SCFA)    nutrition    

The prevailing theory that photosynthetic eukaryotes made their planetary debut when at least one heterotrophic eukaryote engulfed a cyanobacterium signifies a life-altering symbiotic relationship, and a prehistoric association involving a bacterial entity (Margulis, 1974, 1993; Collén et al., 2013; Nowack and Weber, 2018). As multicellularity continued to evolve from this, and other endosymbioses, primitive marine macroalgae arose as being among the first organisms to have cellular interconnections (Cock et al., 2010; Knoll, 2011; Popper et al., 2011). As the massive primordial seas became home to a wide diversity of single celled organisms, plentiful opportunities to establish symbiotic relationships between, and among microbial populations and their hosts, including seaweeds, were exploited. Bacterial-eukaryotic interactions are ubiquitous, and the wide range of influences of bacteria on eukaryotes varies from subtle to profound. Secretions of a newly characterized marine bacterial chondroitinase (EroS), for example, acts like an aphrodisiac by inducing mating in Salpingoeca rosetta (a species of choanoflagellate), one of the closest living relatives to animals (Woznica et al., 2017). The growing realization that microbial influences are significant drivers of a myriad of life processes highlights the evolutionary importance of bacteria and other microbes (collectively called the microbiome) and their relationships to humans, animals and plants (Ikeda et al., 2010; Thomas et al., 2011; Flórez et al., 2015).

The likelihood that, by the very nature of its ready availability along shorelines 2.5 million years ago (mya), (when early human ancestors entered an era of brain development and enhanced cognitive sophistication (Schoenemann, 2006; Holloway et al., 2009; Cunnane and Crawford, 2014) seaweeds would naturally have been part of an increasingly diversified diet for some groups of people. Using a networkbased analysis of RNA gene sequences from the fecal biota of a wide diversity of mammals, Ley et al. (2008) showed that herbivore microbiota contained the greatest variety of phyla, as compared to carnivores and omnivores. It is probable that the ancestors of early Homo sapiens were primarily tree-dwelling herbivores, before they became omnivores, and some groups would have also had access to coastal food resources (Verhaegen and Munro, 2011; Tattersall, 2014). The primitive human biome was developing in concert with a variety of microbes, influencing and adapting to every metabolic system. As a result of this dietary diversification, some gut microbes adapted to process a wider variety of carbohydrates, and many key gut bacteria became generalists, able to contend with an assortment of resources and their subsequent utilization (Stevens and Hume, 1998). Other members of the gut microbiota became specialists, only able to target a few select glycans, but all are elements of a metabolic network where substantial cross-feeding occurs as the by-products of one organism serve as important resources for another (Cockburn and Koropatkin, 2016). Lateral and horizontal gene transfers were, and still are phenomena enabling bacteria to evolve through the acquisition of genetic material from other organisms, offering a competitive, fitness advantage and opportunities for the bacteria to increase in abundance. An extensive sequencing study by Moeller et al. (2016) revealed that clades of the Bacteroidaceae and Bifidobacteriaceae have been maintained exclusively within host lineages across hundreds of thousands of generations, indicating robust co-speciation, facilitated by strong vertical transmission. In addition, sequence analyses provided evidence for extensive sympatry between hosts and their colonizing microbial populations (Sonnenburg, 2010; Blaser, 2018). Hence, the co-evolution of eukaryotes and their commensal, or symbiotic microbial populations must play an important role in the adaptation and fitness of the host (Margulis, 1993; Zilber-Rosenberg and Rosenberg, 2008). Some of these keystone microbial relationships could well have been influenced by dietary seaweeds, highlighting the efficacy of marine macroalgae as a prehistoric and fundamental food.

Recent studies have established that human gut microbes play multiple and essential roles in securing the health and survival of their host (Donia et al., 2014; Cani and Everard, 2016). In addition, specific forms of dysbiosis are clearly associated with the expression of various pathologies, including, among others, inflammation, obesity, cardiovascular diseases, colitis, and neurological disorders (Mazmanian et al., 2008; Chow et al., 2010; Clemente et al., 2012; Le Chatelier et al., 2013; Roszyk and Puszczewicz, 2017). The impacts of the host/microbe interdependence are profound in their influence, encompassing food digestion, carbohydrate fermentation, energy harvesting and storage, gene expression, the secondary generation of beneficial compounds (i.e. cross-feeding), and the facilitation of metabolic functions. Considering the likelihood that seaweeds comprised a readily available and stable food source at the beginning of hominid development and migration (Dillehay et al., 2008; Cornish et al., 2017), it is feasible that the consumption of macroalgae by primitive foragers may have contributed to the establishment of a core group of residential gut microbes. Indeed, marine macroalgae have been challenged by microorganisms throughout their evolution and they continue to evolve in a world of microorganisms (Goecke et al., 2010). These particular microbes probably included members of Firmicutes, Bacteriodetes, and Proteobacteria, the latter two of which are known to digest the galactan sulphates commonly found in red algal cell walls (Miranda et al., 2013). These taxa are also typically found in the healthy human microbiota, although their relative proportions can vary dramatically, depending upon numerous factors, including diet, local environment, genetic pre-disposition, and various personality characteristics associated with the individual (The Human Microbiome Project Consortium, 2012; Lloyd-Price et al., 2016; Davenport et al., 2017). Mammals have evolved an enormous range of digestive strategies and gastrointestinal structures, and in many cases, these anatomic variations are directly linked to the endogenous microbial communities (Stevens and Hume, 1998). Research has shown that microbial diversity in the gut, when low, is a risk factor (and a reliable biomarker) for diseases such as inflammation, obesity and insulin resistance (Le Chatelier et al., 2013). Alternatively, wide genetic diversity in the gut microbial communities is likely to extend the range of environments and resources within which the host can successfully forage for food. An enriched microbiota enhances opportunities for competition and favourable community development, providing important fitness advantages and a vehicle for outcompeting pathogenic microbes (Martens et al., 2014; Sonnenburg et al., 2016).

Compounds produced from the microbial digestion or fermentation of macroalgae are important in the establishment and sustainability of the organisms that utilize them (Jiménez-Escrig et al., 2013). Short chain fatty acid (SCFA) contributions and adaptability programming enhanced by macroalgae in those earliest diets, potentially introduced keystone microbial consortia to the human microbiota. Where diet has such a profound effect on the microbial mix in the human gastrointestinal tract (GIT) (Wu et al., 2011; Sonnenburg et al., 2016), appropriate management of individual and collective food intakes deserves serious investigation. Seaweeds may be considered fundamental, yet complex foodstuffs with an ancient ancestry, and their more broadly-based utilization should be actively investigated. It is noteworthy that many factors can intrinsically influence both the bio-accessibility (release from the food matrix), and the bioactivity (uptake into tissues, metabolism, and physiological effects) of seaweedderived food products, but little research has yet been done in this area (Wells et al., 2017). Furthermore, there is currently limited understanding of nutritional composition across algal species, geographical regions, and seasons, all factors that can substantially influence quality and quantity of nutritive value (Stengel et al., 2011; Wells et al., 2017). Co-evolution of gut microbes and their hosts leads to an interdependence, as clearly demonstrated by the vast array of essential functions provided to the human host by its respective microbiota. Seaweeds were early contributors to the diets of H. sapiens, both directly, and through the animals that consumed macroalgae (Dillehay et al., 2008; Cunnane and Crawford, 2014; Kyriacou et al., 2014) and opportunities for their judicious and regularized utilization in global diets today is worthy of greater study and significance.

2 LITERATURE REVIEW 2.1 Macroalgae and their microbial relationships (co-evolution)

Primitive H. sapiens, as they diverged from their most recent common ancestor, began to develop, or acquire, an increasingly diverse gut microbiota as would be associated with fundamental changes in diet. Adapting to new foods and their associated microbiota is likely to have resulted in synergies leading to the utilization of non-selective energy sources within the host's gut microbiota. The most successful microbes can take advantage of rapid response times to environmental changes, and the ability to degrade a variety of resources. This would enable further GIT development through a system of integration and co-dependence whereby the gut microbiota enter into mutually beneficial partnerships with the host. The contribution of the gut microbiota to the host gene pool is estimated to be over 100 times more than that of the human genome (Qin et al., 2010). These genes encode a diverse array of functions which are actually absent from the human genome, including the considerable number of enzymes needed to process and utilize ingested carbohydrates (Muegge, 2013). Increasing diversity within the gut microbiota provided an increased likelihood of survival opportunities associated with the production of multi-functional metabolites and enhanced nutritional bio-availabilities (Duncan et al., 2008; Kovatcheva-Datchary et al., 2015). It is possible that marine macroalgae may have played a role in the early establishment of a complex, metabolically integrated microbiota, based on selective pressures of diet leading to the fixation of specific variants. These variants, as they increase in frequency, become part of the genetic make-up in the relevant population (Haygood et al., 2007). However, one must be cognizant that accurate determination of the availability and subsequent uptake and utilization of nutrients from a given food matrix remains a significant challenge. This same difficulty exists with establishing the modes of action of the microbiota. Although research is increasingly making important progress, much more work in this area is required (Wells et al., 2017). Nonetheless, it is widely understood that a balance of nutritional inputs must be provided and processed in ways that sustain a synergistic and health-promoting portfolio of microbes necessary to meet the needs of the human host. Research has demonstrated the presence of microbial ecosystems with various species in important symbiotic relationships in plants, humans, and animals, indeed, in all living things (Long, 2001; Zilber-Rosenberg and Rosenberg, 2008; Blaser et al., 2016; Augustin et al., 2017). Gene sequencing and advanced data analysis capabilities are potent tools contributing to the explosion of research in this area regarding the microscopic dimensions of human health and wellness. The present mini-review will focus on those impacts which macroalgal components have had on gut microbiota, with some consideration given to those symbiotic relationships that could have been established early in the evolutionary timeline.

An example of one of the more striking aspects of the symbiotic relationships between algae and bacteria is the mutualism between vitamin B12-synthesizing prokaryotes and certain B12-dependent macro and microalgae (Croft et al., 2005; Croft et al., 2006; Kazamia et al., 2012). Pyropia (Porphyra) is considered one of the most ancient genera of macroalgae, belonging to the Order Bangiales, a primitive group of seaweeds, and quite feasibly the precursors to the red algal clade (De Clerck et al., 2012). Pyropia spp. have been demonstrated to be a viable dietary source of B12 (Rauma et al., 1995; Watanabe et al., 2014), a vitamin essential to human health and development, but one which we are unable to produce ourselves. Scientists continue to question the processes underlying how species become dependent on an external source of essential micronutrients and the prevailing theory is that vitamin availability drives selection for vitamin dependence. This approach invariably links an organism's metabolic processes to its early environment (Helliwell et al., 2015), and offers some support regarding a dependable and long-term coastal diet for primitive H. sapiens. During the period of primitive brain development and enlargement, a stable source of B12, (cobalamin) essential for cognition and memory, could have been derived from a stable diet containing Pyropia spp. Prokaryotes are the only organisms that synthesize this important vitamin, and other sources at the time before the advent of tools and fire would include eggs, possibly scavenged meat, and fish, foods unlikely to be available on a long-term and consistent basis to early foragers. Although corrinoids are produced in the large intestine due to the activity of the gut microbiota, cobalamin produced here, where microbial numbers are highest, is not bioavailable because the receptors necessary for absorbing the vitamin are found in the small intestine, upstream of the site of corrinoid production (Seetharam and Alpers, 1982). In humans, the stomach releases an intrinsic factor that is essential for dietary vitamin B12 absorption in the small intestine (Wells et al., 2017). Cobalamin has also been reported in other non-animal foods, such as mushrooms and other edible algae (Watanabe et al., 2014). Without an adequate supply of vitamin B12, newborn infants express symptoms of cerebral and optic nerve atrophy, apathy and coma, hypotonia, and developmental delay (Von Schenck et al., 1997; Roumeliotis et al., 2012). Maternal intake must be sufficient during the nine-month human gestation period, and there remains a necessity for dietary replenishment during lactation. In a detailed chart review of 27 infants in India, Goraya et al. (2015) noted B12 deficiency symptoms which included lethargy, irritability, feeding difficulties, refusal of solid foods, pallor, and failure to thrive, followed by neurodevelopmental regression. Thus, the historical importance of dietary seaweeds, which, while unlikely to be "proven", should not be dismissed.

Certain microbe/algal symbioses may contribute to improved growth rates, as in the case of Bacillus sp. WPySW2 and Pyropia haitanensis (Xiong et al., 2017), induced morphological changes (Provasoli and Pintner, 1980; Marshall et al., 2006), and effects on metabolic activities, defense mechanisms, hormone production, and oxidative imbalances (Garbary and London, 1995; Armstrong et al., 2001; Goeck et al., 2010; Singh et al., 2011; Singh and Reddy, 2014 and the references therein). An extensive evolutionary timeline has contributed to multiple opportunities for horizontal gene transfers to occur in macroalgae (Collén et al., 2013). This mechanism of transfer has also been discovered in humans whereby the gene encoding for specific seaweed carbohydratedegrading enzymes has been acquired by the gut bacterium Bacteriodes plebeius in certain groups of people (Hehemann et al., 2010; Rebuffet et al., 2011). An example of this became known among the general public as the sushi factor in the case of a common Japanese seaweed product nori produced by Pyropia spp. and often used for sushi. Hehemann et al. (2012), found that a portion of the Japanese population had gut enzymes that could break down porphyran from Pyropia whereas a population of North Americans did not. Pyropia is an ancient edible seaweed resource commonly consumed by people in Japan since the 6th century (Mouritsen, 2013). In a recent study by Kearney et al. (2018), B. plebeius was shown to colonize the mouse gut at high levels in the presence of an introduced, preferred substrate, i.e. Pyropia sp., with no evidence of competition for this substrate by native gut bacteria. The authors suggested that these results highlighted the possibility of seeding the gut microbiota with an appropriate substrate, matched with its microbial degradation partner through a process of re-programming a diet for therapeutic benefits.

Many diseases have been linked to the Western diet, and compared to more traditional food regimes, such a diet has led to a significant reduction in certain microbiota accessible carbohydrates (MACs) typically found in dietary fibres. Studies by Sonnenburg et al. (2016) using mice colonized with human gut microbiota illustrated an increasing loss of microbial diversity over generations as a result of dietary limitations of MACs, ultimately resulting in an unrecoverable loss of taxa, in particular, members of the Bacteriodetes. This preliminary research in mice led the authors to emphasize the importance of utilizing a variety of substrates for the maintenance of a diverse and healthy gut microbiota. They also suggested that as global initiatives to investigate precision medicine are launched (Riscuta et al., 2018), strategies to therapeutically target microbiota should involve the incorporation of MACs, as well as taxa not currently present in the Western diet. While numerous studies showed that short-term changes in diets can rapidly alter the GIT microbial populations, it is the long-term diet that better correlates to the specific enterotypes clustering in the human gut (Wu et al., 2011; Roszyk and Puszczewicz, 2017). It is the authors' view that marine macroalgae, with its long history of utilization as a natural and nutritional foodstuff within a wide variety of cultures (Mouritsen, 2013) should be given serious consideration as a standardized prebiotic. Obviously, research to further verify this functionality must advance beyond animal models to include well-structured and focused human trials.

Of interest is the inability of humans to process a range of carbohydrates beyond starch, and simple sugars such as sucrose and lactose, and therefore we are dependent upon microbial degradation of most dietary polysaccharides to release essential metabolites and make available nutritional compounds (Stevens and Hume, 1998; Sonnenburg, 2010; Cantarel et al., 2012; El Kaoutari et al., 2013). The diversity and quality of marine macroalgal microbiomes present millions of years ago would set a precedent for human nutrition based upon a system of co-evolution in those groups of individuals with access to a shore-based diet. The fossil record indicates that humans diverged from a common ancestor approximately 5–7 mya (Holloway et al., 2009), and that macroalgae had been already prominent on the planet for at least 540 million years prior to that (Leliaert et al., 2016). In an extensive review of genomics sequencing data, Thomas et al. (2011) highlighted the diversity of Bacteroidetes, keystone, mutualistic members of the human GIT, equipped with numerous carbohydrate-active enzymes covering a broad spectrum of substrates, from plant, algal, and animal origin. The authors stated that this functional diversity had evolved through dynamic processes over evolutionary time, driven by highly frequent genetic rearrangements, gene duplications, and lateral gene transfers. Current science is only at the outer periphery of identifying and understanding all of the complex interactions and permutations of microbes and microbial enzymes within the GIT. For example, in a study analyzing the genetic composition of gastrointestinal bacteria of 397 people of various ages and nationalities, 850 bacterial genera that could potentially metabolize at least one foreign or exogenous substance were identified (Das et al., 2016). The ability to determine the precise bioavailability of macroalgal compounds in the human GIT may still be quite some time in the future.

2.2 Humans and gut microbiota

A well-functioning human body results from the culmination of ongoing interactions of numerous dynamic consortia of microbes, all members of communities or niches, often within other communities, and widely influenced by the host's diet. Other influential factors exist, such as genetics, environment, antibiotic regime, and individual predisposition, but diet constitutes one of the most pertinent attributes leading to health management, and the food is processed and transformed into nutrients and bioactive compounds primarily via the gut microbiota. Extensive investigative studies are establishing the multiple roles played by gut microbes in the manifestation of human health and disease. Microbially-mandated immune functions have widespread biological and physiological impacts, and microbial dysbiosis in the gut underlies multiple human pathologies related to immunity, including rheumatoid arthritis, inflammatory bowel diseases (IBDs) such as Crohn's disease and ulcerative colitis (Elson, 2000; Mazmanian et al., 2005; Clemente et al., 2012; Nanjundappa et al., 2017; Roszyk and Puszczewicz, 2017). Other conditions leading to detrimental health issues have also been shown to be impacted by gut microbiota and the uncontrolled proliferation of unfavourable (pathogenic) species, as they gain an advantage and out-compete beneficial strains. This can result in metabolic disorders such as obesity, diabetes, blood flow regulation/hypertension, sleep deprivation disorders, and various forms of neurological dysfunction (Benedict et al., 2016; Cani and Everard, 2016; Thiba et al., 2017; Farzi et al., 2018; Jocken et al., 2018). Fundamental to the effective maintenance of a health-promoting microbial profile, is the appropriate management of that system through its energy/food source. As an example, the efficiency with which the microbiota degrade polysaccharides relates to the calories the host can extract from its diet, potentially influencing the survival and fitness of both host and microbiota, in a truly mutualistic association (Sonnenburg, 2010; Cockburn and Koropatkin, 2016). The nature of the metabolites produced by microbial degradation adds to the web of functional inter-dependence, and the product mix is dependent upon the substrates provided to the GIT.

An important health-promoting product of beneficial gut bacteria are the short chain fatty acids (SCFA), e.g. propionate, butyrate, and acetate, which are derived from dietary fibre (i.e. polysaccharides/ oligosaccharides). These are normally resistant to digestion in the small intestine and are fermented in the large bowel. It is surmised that both the amount and relative abundance of SCFAs may be considered as biomarkers of a healthy status (Ríos-Covián et al., 2016). The nutritional substrates provided to the gut microbiota present multiple opportunities within the microbiota, and these unicellular organisms switch metabolic status accordingly, so as to maintain their associated niche population homeostasis. To demonstrate this mechanism, an investigation into the effects of a food-grade antimicrobial agent on the gut microbiota in a mouse model ultimately revealed only a transient perturbation of the microbial community, indicating a dynamic but resilient microbiome (You et al., 2017). This plasticity of endogenous microbial populations in the gut is a strong selection factor related to host fitness. The ability of bacteria to multiply rapidly and to adapt to new environments is a well-known characteristic, and a highlight of their persistence and evolutionary success. Biological systems favour community robustness, which is often based upon various symbiotic relationships, and SCFAs play a major role as mediators of function and facilitators of the provision of energy. SCFAs are absorbed and used in different biosynthetic pathways by the host such as shaping the gut environment, thereby influencing the physiology and structure of the colon, acting as energy sources for host cells and the intestinal microbiota themselves, whilst also participating in different host-signaling mechanisms (Den Besten et al., 2013). SCFAs may also regulate cell proliferation through the release of growth factors or gastrointestinal peptides, or additionally, through the modulation of mucosal blood flow. SCFAs are also known to influence the genes regulating cell proliferation (Siavoshian et al., 2000; Blottière et al., 2003; Ríos-Covián et al., 2016).

Of utmost significance is the influence SCFAs have on brain function via the bi-directional hypothalamic pituitary adrenal (HPA) axis, sometimes referred to as the gut/brain/microbiota axis. These important fatty acids are critical factors in the maturation and function of microglia, which in turn acts as the primary form of active immune defence in the central nervous system (CNS) (Erny et al., 2015). Butyrate not only exerts anti-depressant effects in humans, it plays a significant role in the intervention of neuro-degenerative diseases and psychiatric disorders (Farzi et al., 2018). Both butyrate and propionate can modulate brain functioning, in particular appetite and energy homeostasis through the regulation of neuro-peptide production (Bourassa et al., 2016; Oriach et al., 2016). Mechanisms by which the microbiota influences the gut-brain axis include modification of autonomic/ sensorimotor connections, immune activation, neuroendocrine pathway regulations, and interactions between microbial metabolites and the blood-brain barrier (Hoyles et al., 2018; Wang et al., 2018b). Furthermore, studies have shown that microbegenerated metabolites were intrinsically integrated within host cell biochemistry and physiology and SCFA-mediated cell-signaling is a key pathway used by microbes to communicate with the host (Cryan and Dinan, 2012; Moos et al., 2016 and references therein). However, abnormally elevated levels of certain SCFAs appeared to be linked to deleterious effects on human health and wellness, such as obesity and cognitive issues in autistic children (MacFabe, 2013; Perry et al., 2016), but, a definitive cause and effect has not yet been clearly identified, and research continues in this area. In the case of butyrate, for example, the general view was that sufficient butyrate production by the gut microbiota is a crucial component for maintaining host health, but chronic imbalances in its supply and utilization could facilitate the manifestation of disease. Key gut microbes critical to the production of butyrate encompass taxa from various Firmicutes families and some Bacteroidetes (Vital et al., 2017), which suggested that foods promoting the colonization and maintenance of these species were likely to also contribute to overall health benefits. Caution must be applied to such a simplified approach however, as excesses of gastrointestinal Firmicutes sp. have been associated with obesity, as is low bacterial richness in general, and research is still at the very early stages of providing an understanding of the various complexities around diet and microbial interactions (Ley et al., 2005, 2006; Davenport et al., 2017). For instance, we do not yet know whether the individual molecule, gene, pathway, strain, genus, family, consortia of co-operating species, or other combination is most relevant to human health and disease (Cani and Everard, 2016; Blaser, 2018). Research is responding, and Tramontano et al. (2018) have taken steps to determine the optimum nutrient requirements of a representative set of human gut microbes, 96 bacterial strains from 72 species over 19 different media. The results of that work highlighted robust growth in defined media, in many cases better in defined than in rich media, and interestingly, several species showed inhibitory responses to SCFAs and amino acids. The authors suggested that other factors could possibly account for this, such as an accumulation of toxic intermediates or pH imbalances, and further research is underway.

2.3 Dietary seaweeds

Metagenomic analysis of fecal DNA extracted from 33 distinct mammalian species indicated that all gut microbiota appeared to share a large core group of genes, but that the host diet strongly influenced their relative abundance and functionality (Muegge, 2013). The data showed that total protein intake was significantly correlated with the functional profile of the community, whilst fibre intake was significantly related to both the species composition and SCFA production. Virtually all the SCFAs circulating in the bloodstream are microbial in origin. Changes in SCFAs would indicate activity of the gut microbiota, which in turn would be based largely on the substrates provided to it (Bourassa et al., 2016). Non-digestible soluble fibre, such as polysaccharides (and their oligosaccharides) constitute over half of the total fibre content in seaweeds (Lahaye, 1991), and its utilization in the large intestine has been demonstrated to provide butyrate, propionate, and acetate (Liu et al., 2015). These particular soluble fibres are termed 'functional fibres' because they confer health benefits in humans.

Algal-derived, marine oligosaccharides are broadly classified into different groups depending upon their chemical diversity. For example, there are chitosan-, laminarin-, alginate-, fucoidan(s)-, carrageenan(s)-, and ulvan-oligosaccharides (Jutur et al., 2016). However, many of these fibres are not completely fermented by colonic bacteria, but various degrees of fermentation do occur, and are likely to vary by seaweed species, polysaccharide portfolio, and presence or absence of appropriate colonic microbiota (Holdt and Kraan, 2011; Williams et al., 2013; Chen et al., 2018; Zhang et al., 2018). Carbohydrates are known to fuel the Acetyl Coenzyme A (CoA) pathway, and this pathway dominates butyrate synthesis (Vital et al., 2017).

Quantifying the bioavailability, or fraction of nutritional or functional components that actually have an effect in relation to their residence time in the digestive system remains a significant limitation, and a full understanding of the various processes and mechanisms is far from realization. For example, Salvia-Trujillo et al. (2015) compared bioavailability of fucoxanthin (an accessory pigment, a xanthophyll, found in most brown seaweeds) under in vitro and in vivo (rats) conditions using nano-emulsion delivery systems with different carrier oils. While the fucoxanthin was absorbed into the intestinal epithelium in the same order in rats as observed for the in vitro solubility tests, the serum concentration was similar for all carrier oils, suggesting unanticipated internal biological activities. Determining bioavailability of specific nutrients remains a significant challenge regardless of food source.

The oligosaccharide components of marine macroalgae are both numerous and varied, and often influenced by season and other environmental factors, conditions of practical importance to commercial entities, and well known in general. Laminarin is a storage polysaccharide found exclusively in brown seaweeds. It is not hydrolyzed by the human endogenous digestive enzymes (Devillé et al., 2007), but it has been shown to be used by human intestinal bacteria in an in vitro fermentation study. The resultant SCFAs in this study were primarily acetic, propionic and butyric acids, i.e. 63.96%, 25.91%, and 8.16% respectively (Devillé et al., 2007). In a six week feeding trial, adult rats fed different rates of a mineral blend containing ingredients isolated from the red seaweed, Lithothamnion sp. showed differences in caecal SCFA composition. There was a significant increase in propionate with the 0.1% mineral blend over the control and a significant increase in butyrate in the 0.1% blend compared to those receiving the 0.2% rate. The 0.1% supplemented group also contained significantly more bacterial diversity than the control group (Crowley et al., 2018). Assessing the bioavailability of these ingredients from the whole algae in the diet is an area worthy of further research.

In one of the earliest studies to assess the prebiotic potential of the red seaweeds, Chondrus crispus, and Sarcodiotheca gaudichaudii in layer hens, Kulshreshtha et al. (2014) supplemented a standard poultry diet with powdered whole seaweed biomass (at rates of 0.5%, 1%, and 2% wt/wt) of each species. The seaweed diets were found to increase the abundance of beneficial bacteria, reduce the prevalence of pathogenic bacteria, and significantly increase the concentration of SCFAs in the cecal digesta. Acetic acid content was greater in the birds fed 1% Sarcodiotheca gaudichaudii or Chondrus crispus (52.21 mmol/kg; 51.53 mmol/kg, respectively) as compared to either the basal diet (29.94 mmol/kg), or the industry prebiotic standard, inulin (36.11 mmol/ kg). The concentration of both propionic and butyric increased 2-to 3-fold in the seaweed treatments.

In a follow-up study to assess the prebiotic effects of a cultivated red seaweed, C. crispus, Liu et al. (2015) compared the results of supplementing rat feed with either 2.5%, or 0.5% dried, ground seaweed to diets including the same rates of fructo-oligosaccharide (FOS/inulin), with a standard basal diet as the control. In the 2.5% feed supplementation with C. crispus, the concentration of the three primary SCFAs increased significantly, as compared to the control group, and similarly, acetic and butyric acids significantly increased in the 0.5% group. Fructooligosaccharide (FOS) supplementation also increased SCFA over the control, but that difference was not significant. Furthermore, in the seaweed supplemented diet, there was an increased abundance of beneficial colonic microbiota and a concomitant decrease in pathogenic microbes.

Kappaphycus alvarezii is a red seaweed typically grown for utilization in the food/hydrocolloid industry, generally as a cultivated biomass for the production of industrial gums (i.e. kappa carrageenan). However, recent initiatives to investigate other applications led to research indicating that this seaweed also has prebiotic potential. An in vitro colon model showed that K. alvarezii significantly increased total SCFA production, especially acetate and propionate, and it also significantly increased the Bifidobacterium sp. count, which are considered to be beneficial bacteria (Bajury et al., 2017). Feeding a supplement of dried and milled K. alvarezii (at 5% w/w) to rats receiving a high fat diet designed to induce metabolic syndrome symptoms demonstrated positive effects on their gut microbiota by selecting against increases in Firmicutes (excesses are also associated with obesity) and promoting Bacteroidetes (Wanyonyi et al., 2017).

Other research investigating the prebiotic effects of seaweeds or their extracts has focused on members of the Phaeophyta, which, in the case of Saccharina latissima, increased some of the SCFA content in healthy rats. Acetic and propionic concentrations in the seaweed-treated rats increased to 15.07 and 28.43 μmol/g dw respectively, as compared to the control, 10.19 and 19.12 μmol/g dw (Jiménez-Escrig et al., 2013). Other measures of the prebiotic potential of dietary seaweeds relates to modifications of microbial species in favour of those groups deemed beneficial to the host. An extract derived from Laminaria digitata, containing laminarin and fucoidan increased the digestibility of feed components and reduced pathogenic bacteria in newly weaned pigs, and these results also contributed to the overall health improvements of the pigs in this study after weaning (O'Doherty et al., 2010). Feed supplementation for rams with a commercial, airdried brand of Ascophyllum nodosum, Tasco clearly modified their microbiota communities and reduced pathogenic bacterial levels (e. g. E. coli) (Zhou et al., 2018). In addition, Okolie et al. (2017) published a review tabulating numerous trials indicating prebiotic activity and immune stimulatory responses to brown seaweed polysaccharides (BSP). These included β-glucans and laminarin from L. digitata, a fucoidan from L. japonica, low molecular weight polysaccharides from A. nodosum, and a range of BPS from Ecklonia radiata.

Kim et al.(2016, 2018) conducted studies on the impact of supplementing standard rat diets with Undaria pinnatifida or Laminaria japonica on the intestinal microbiota and the production of metabolites. The results of these studies indicated that adding those seaweeds to rat diets demonstrated multiple prebiotic effects including enhanced immune response and desirable changes in microbiota composition. Anti-obesity characteristics (proliferations of leanness-associated bacterial genera and increased production of butyric acid) were also apparent.

There are reports that seaweed polysaccharides are not fully fermentable in the large intestine (Holdt and Kraan, 2011), but evidence of increased levels of SCFAs in most investigations suggests reasonable functionality, at least in animal models. SCFA concentrations and bacterial composition are the most common prebiotic-based measures of the gut microbiota (Sawicki et al., 2017). However, it is also possible that dietary seaweeds could exert a positive impact on the microbial communities in the gut through other mechanisms, such as localized pH modifications, nutrient provision, regulation of gut metabolism, and by influencing cross-talk and general improvements in the GIT environment through increased hydration and enhanced surface area of the intestinal epithelium (Cian et al., 2015; Liu et al., 2015; De Jesus Raposo et al., 2016). Any selectively fermented ingredient that results in specific changes in the composition and/or activity of the GI microbiota and conferring health benefits upon the host is considered a prebiotic (Gibson et al., 2010). However, recent developments in community-wide sequencing and glycomic analyses have revealed that more complex interactions occur between putative prebiotic substrates and the gut microbiota than previously considered (Hutkins et al., 2016) and increased production of SCFAs is not the only measure of benefits. There are novel pathways by which gut microbes interact with host cells and vice versa, readily leading to changes in gut barrier and metabolic inflammation (Cani and Everard, 2016), and components in dietary seaweeds are possible candidates for conferring positive influences. As sequencing technologies continue to advance, new species-level insights can be gained in the study of complex and therapeutically important microbial communities and their interaction with food-based substrates within the GIT. These should be carefully scrutinised over the coming years for leads related to the benefits of consumption of seaweeds on gut microbiota and human health.


Scientists have now acquired a basic understanding of what constitutes a healthy human microbiome through cross-disciplinary studies correlating deviations from the healthy state to a wide range of known maladies. The impacts of gut microbiota are so extensive and widespread that the collective human microbiome itself may be considered as an "organ" that interacts with other metabolic systems in order to perform specific critical functions within the body (O'Hara and Shanahan, 2006). There is increasing evidence that the gut microbiota are an integral component of human physiology, with an important role in shaping both the innate and adaptive immune responses (Round and Mazmanian, 2009; West et al., 2015). The intestinal microbiota is also an important component of the mucosal barrier, the outermost layer of the intestinal epithelium and the largest area of the gut in contact with the external environment. In the mucosal layer, an effect of prebiotic administration enables the host to modify the intestinal microbiota through the production of mucus, secretory immunoglobulin, or anti-microbial peptides, while the microbiome shapes the immune response, interacting with receptors located in the intestinal epithelial cells, dendritic cells, or macrophages (Cian et al., 2015). Increased villi height and deeper crypt depth in the ileum are also beneficial effects of prebiotics (as demonstrated by red seaweed supplements in model animal trials), providing more surface area for housing innate populations of commensal microbial communities (Kulshreshtha et al., 2014). This is a microbially-mediated health benefit not only for the host, but also for the microbiota. The scientific world exploring the gut microbiota and humans has reached new dimensions, and definitions and terminologies continue to evolve in parallel. Ultimately, if a food enhances the gut microbiota in a way that is beneficial for the host, it remains a positive effect, regardless of the terminology used to describe it. In the present review, the focus is supported by the current expert consensus for the definition of a prebiotic: 'a substrate that is selectively utilized by host microorganisms conferring a health benefit' (Gibson et al., 2017). A significant amount of published data already exists regarding the many health benefits attributed to the judicious intake of dietary seaweeds, but more cross-disciplinary studies are required to further assess the specific prebiotic effects in humans of this natural and ancient food in humans. In the Plant Kingdom, seaweed extracts have been shown to enhance the beneficial microbial communities associated with them, conferring fitness opportunities and productivity advantages (Alam et al., 2013, 2014; Wang et al., 2018a). The studies listed in this review clearly suggest that similar effects could apply to the microbiota co-inhabiting with humans and animals.

With such profound importance associated with the gut microbiota in relation to human health and wellness, and evidence for the detrimental loss of diversity (Moeller et al., 2016; Sonnenburg et al., 2016) within this 'forgotten organ' it would seem pertinent to investigate the offerings of the descendants of ancient seaweeds. An enlightening, newly developed database of intervention studies for applications of dietary fibres in human nutrition identified 188 studies, each with at least one outcome related to the gut microbiome. Results of this 'evidence map' identified 47 different fibre types, with oligosaccharides (i.e. 20% of the studies) the most frequently studied, followed by resistant starch (16%), chemically synthesized fibres (15%), inulin (13%), bran (13%), and cereal fibre (11%) (Sawicki et al., 2017 for further details). While it is possible that some macroalgal studies were included in these groups, it may also be unlikely, as seaweeds do not typically overly interest non-phycologists (yet), and there are currently some industrial limitations regarding standardized macroalgal products available to the western diet.

The widespread use of antibiotics in agriculture and healthcare has led to significant issues around antimicrobial resistance associated with perturbations of the innate microbial communities present in the GIT. The rise of antibiotic resistant pathogens also promotes microbial dysbiosis and allows opportunistic pathogens to flourish, to the detriment of the host. This is another arena where dietary seaweeds can play important roles, as they have co-evolved for millions of years in an environment rich in microbes which were the first colonizers on earth, and numerous studies have demonstrated important in vitro antimicrobial activities of seaweeds (Cox et al., 2014; Kadam et al., 2015; Kausalya and Narasimha Rao, 2015; Pérez et al., 2016). While such effects are seemingly counter-intuitive to the promotion of dietary seaweeds as robust prebiotic resources, the field of microbiology in relation to diet and concomitant human health is extremely complex. Ultimately, it is the collaborative relationships microbial communities develop and maintain within an often loosely balanced, but dynamic system, which facilitate the expression of health and wellness for all participants. Human development (meat-eating, cooking, and consumption of highly processed foods) has significantly altered the innate microbial communities present in the GIT over the evolutionary timeline, particularly in westernized societies, but there may remain traces of those earliest inhabitants falling under the auspices of cryptic-genetic variation. This concept contends that the visible genetic diversity observed in populations is only a fraction of the potential diversity that standing genetic variation can produce, and environmental changes can stimulate expression of previously hidden phenotypes (Gibson and Dworkin, 2004). Viable methods to help detract societies from diets containing high fat, salt, and sugar components, and heavily processed foods must continue to be investigated in the interest of facilitating health and wellness. While still far from being scientifically proven, the addition of dietary seaweeds as a component of the Westernized diet may well provide functional benefits.

These are fascinating times when so many tools to investigate the myriad of relationships between humans and their microbiomes are becoming increasingly available and accessible. It is ironic that modern industrial societies appear to have lost more than half their GIT microbial diversity (Sonnenburg et al., 2016; Davenport et al., 2017), and at the same time developmental diseases related to inflammation, neurological irregularities, obesity, and immune deficiencies are increasingly prevalent. There is consensus within the scientific community that there must be great importance attached to the restoration of a diverse and well-balanced gut microbiome (Blaser and Falkow, 2009). This will be far from simple but a logical step in the right direction would point to the inclusion of a food such as seaweed, with a very long and positive history of co-evolution and consumption. Symbiotic (commensal) relationships may have been established in the early hominid microbiota of those who consumed it as a dietary staple, as in the case of B. plebeius and porphyranase production (Hehemann et al., 2010; Rebuffet et al., 2011). As Blaser (2018) suggested, we may first need to prime our systems with seed, and then fertilize the true, and currently extinct, probiotic organisms with specific prebiotics in order to maintain and prolong our evolutionary fitness. Much akin to a re-set position to serve as the foundation upon which to build health and wellness truly from within, and based upon fundamental nutritional elements in terms of microbial substrate degradation. Consider, for example, that today, on a global scale, neuro-degenerative diseases such as Alzheimer's, dementia, depression, Parkinson's, etc., are on the rise, and these and other non-communicable diseases have surpassed infectious diseases as the principal cause of death, particularly in developed countries (Moos et al., 2016; Global Burden of Disease Collaborators, 2017; WHO (World Health Organization), 2018). There is evidence strongly linking these diseases to gut dysbiosis, and it is likely that a return to fundamental foods, including the types of nutritional resources early H. sapiens may have eaten during a time when brain size and its cognitive sophistication were expanding, is in order.

In this context, it is important to remark that with a diet that, due to the industrial processing of food, is increasingly more sterile and less contaminated with natural and environmental microorganisms, the diversity and robustness of the human microbiota is diminished. A similar remark is in order with regard to the reduced microbiota with newborn children who have been delivered under sterile conditions by a caesarian (Moya-Pérez et al. 2017).

It is exciting to read every day of new developments in this area of research, feeding the global knowledgebase, but the sheer magnitude of the number of variables may temporarily slow widespread therapeutic applications. However, there is significant interest, convincing rationale, and a certain sense of urgency to promote the judicious consumption of seaweed-based products for the establishment and maintenance of a healthy human microbiota. We suggest that this is a critical area for further human health, wellness, and nutritional research.


The work by OGM was supported by Nordeafonden via a center grant to the national Danish center Taste for Life.

The authors would like to thank anonymous reviewers of the journal for their careful scrutiny and constructive comments which improved the manuscript.

Alam M Z, Braun G, Norrie J, Hodges D M. 2013. Effect of Ascophyllum extract application on plant growth, fruit yield and soil microbial communities of strawberry. Can.J. Plant Sci., 93(1): 23-36. DOI:10.4141/cjps2011-260
Alam M Z, Braun G, Norrie J, Hodges D M. 2014. Ascophyllum extract application can promote plant growth and root yield in carrot associated with increased root-zone soil microbial activity. Can. J. Plant Sci., 94(2): 337-348. DOI:10.4141/cjps2013-135
Armstrong E, Yan L M, Boyd K G, Wright P C, Burgess J G. 2001. The symbiotic role of marine microbes on living surfaces. Hydrobiologia, 461(1-3): 37-40.
Augustin R, Schröder K, Rincón A P M, Fraune S, AntonErxleben F, Herbst E M, Wittlieb J, Schwentner M, Grötzinger J, Wassenaar T M, Bosch T C G. 2017. A secreted antibacterial neuropeptide shapes the microbiome of Hydra. Nat. Commun., 8(1): 698. DOI:10.1038/s41467-017-00625-1
Bajury D M, Rawi M H, Sazali I H, Abdullah A, Sarbini S R. 2017. Prebiotic evaluation of red seaweed (Kappaphycus alvarezii) using in vitro colon model. Int. J. Food Sci.Nutr., 68(7): 821-828. DOI:10.1080/09637486.2017.1309522
Benedict C, Vogel H, Jonas W, Woting A, Blaut M, Schürmann A, Cedernaes J. 2016. Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals. Mol.Metab., 5(12): 1175-1186.
Blaser M J, Cardon Z G, Cho M K, Dangl J L, Donohue T J, Green J L, Knight R, Maxon M E, Northen T R, Pollard K S, Brodie E L. 2016. Toward a predictive understanding of Earth's microbiomes to address 21st century challenges. mBio, 7(3): e00714-16. DOI:10.1128/mbio.00714-16
Blaser M J, Falkow S. 2009. What are the consequences of the disappearing human microbiota?. Nat. Rev. Microbiol., 7(12): 887-894. DOI:10.1038/nrmicro2245
Blaser M J. 2018. The past and future biology of the human microbiome in an age of extinctions. Cell, 172(6): 1173-1177. DOI:10.1016/j.cell.2018.02.040
Blottière H M, Buecher B, Galmiche J P, Cherbut C. 2003. Molecular analysis of the effect of short-chain fatty acids on intestinal cell proliferation. Proc. Nutr. Soc., 62(1): 101-106. DOI:10.1079/PNS2002215
Bourassa M W, Alim I, Bultman S J, Ratan R R. 2016. Butyrate, neuroepigenetics and the gut microbiome:can a high fiber diet improve brain health?. Neurosci. Let., 625: 56-63. DOI:10.1016/j.neulet.2016.02.009
Cani P D, Everard A. 2016. Talking microbes:when gut bacteria interact with diet and host organs. Mol. Nutr.Food Res., 60(1): 58-66. DOI:10.1002/mnfr.201500406
Cantarel B L, Lombard V, Henrissat B. 2012. Complex carbohydrate utilization by the healthy human microbiome. PLoS One, 7(6): e28742. DOI:10.1371/journal.pone.0028742
Chen L G, Xu W, Chen D, Chen G J, Liu J W, Zeng X X, Shao R, Zhu H J. 2018. Digestibility of sulfated polysaccharide from the brown seaweed Ascophyllum nodosum and its effect on the human gut microbiota in vitro. Int. J. Biol.Macromol., 112: 1055-1061.
Chow J, Lee S M, Shen Y, Khosravi A, Mazmanian S K. 2010. Host-bacterial symbiosis in health and disease. Adv.Immunol., 107: 243-274. DOI:10.1016/B978-0-12-381300-8.00008-3
Cian R E, Drago S R, de Medina F S, Martínez-Augustin O. 2015. Proteins and carbohydrates from red seaweeds:evidence for beneficial effects on gut function and microbiota. Mar. Drugs, 13(8): 5358-5383.
Clemente J C, Ursell L K, Parfrey L W, Knight R. 2012. The impact of the gut microbiota on human health:an integrative view. Cell, 148(6): 1258-1270. DOI:10.1016/j.cell.2012.01.035
Cock J M, Sterck L, Rouzé P, Scornet D, Allen A E, Amoutzias G, Anthouard V, Artiguenave F, Aury J M, Badger J H, Beszteri B, Billiau K, Bonnet E, Bothwell J H, Bowler C, Boyen C, Brownlee C, Carrano C J, Charrier B, Cho G Y, Coelho S M, Collén J, Corre E, Da Silva C, Delage L, Delaroque N, Dittami S M, Doulbeau S, Elias M, Farnham G, Gachon C M, Gschloessl B, Heesch S, Jabbari K, Jubin C, Kawai H, Kimura K, Kloareg B, Küpper F C, Lang D, Le Bail A, Leblanc C, Lerouge P, Lohr M, Lopez P J, Martens C, Maumus F, Michel G, Miranda-Saavedra D, Morales J, Moreau H, Motomura T, Nagasato C, Napoli C A, Nelson D R, Nyvall-Collén P, Peters A F, Pommier C, Potin P, Poulain J, Quesneville H, Read B, Rensing S A, Ritter A, Rousvoal S, Samanta M, Samson G, Schroeder D C, Ségurens B, Strittmatter M, Tonon T, Tregear J W, Valentin K, Von Dassow P, Yamagishi T, Van De Peer Y, Wincker P. 2010. The Ectocarpus genome and the independent evolution of multicellularity in brown algae. Nature, 465(7298): 617-621.
Cockburn D W, Koropatkin N M. 2016. Polysaccharide degradation by the intestinal microbiota and its influence on human health and disease. J. Mol. Biol., 428(16): 3230-3252. DOI:10.1016/j.jmb.2016.06.021
Collén J, Porcel B, Carré W, Ball S G, Chaparro C, Tonon T, Barbeyron T, Michel G, Noel B, Valentin K, Elias M, Artiguenave F, Arun A, Aury J M, Barbosa-Neto J F, Bothwell J H, Bouget F Y, Brillet L, Cabello-Hurtado F, Capella-Gutiérrez S, Charrier B, Cladière L, Cock J M, Coelho S M, Colleoni C, Czjzek M, Da Silva C, Delage L, Denoeud F, Deschamps P, Dittami S M, Gabaldón T, Gachon C M, Groisillier A, Hervé C, Jabbari K, Katinka M, Kloareg B, Kowalczyk N, Labadie K, Leblanc C, Lopez P J, McLachlan D H, Meslet-Cladiere L, Moustafa A, Nehr Z, Nyvall Collén P, Panaud O, Partensky F, Poulain J, Rensing S A, Rousvoal S, Samson G, Symeonidi A, Weissenbach J, Zambounis A, Wincker P, Boyen C. 2013. Genome structure and metabolic features in the red seaweed Chondrus crispus shed light on evolution of the Archaeplastida. Proc. Natl. Acad. Sci. U. S. A., 110(13): 5247-5252.
Cornish M L, Critchley A T, Mouritsen O G. 2017. Consumption of seaweeds and the human brain. J. Appl. Phycol., 29(5): 2377-2398.
Cox S, Turley G H, Rajauria G, Abu-Ghannam N, Jaiswal A K. 2014. Antioxidant potential and antimicrobial efficacy of seaweed (Himanthalia elongata) extract in model food systems. J. Appl. Phycol., 26(4): 1823-1831. DOI:10.1007/s10811-013-0215-0
Croft M T, Lawrence A D, Raux-Deery E, Warren M J, Smith A G. 2005. Algae acquire vitamin B12 through a symbiotic relationship with bacteria. Nature, 438(7064): 90-93. DOI:10.1038/nature04056
Croft M T, Warren M J, Smith A G. 2006. Algae need their vitamins. Eukaryot Cell, 5(8): 1175-1183. DOI:10.1128/EC.00097-06
Crowley E K, Long-Smith C M, Murphy A, Patterson E, Murphy K, O'Gorman D M, Stanton C, Nolan Y M. 2018. Dietary supplementation with a magnesium-rich marine mineral blend enhances the diversity of gastrointestinal microbiota. Mar. Drugs, 16(6): 216. DOI:10.3390/md16060216
Cryan J F, Dinan T G. 2012. Mind-altering microorganisms:the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci., 13(10): 701-712. DOI:10.1038/nrn3346
Cunnane S C, Crawford M A. 2014. Energetic and nutritional constraints on infant brain development:implications for brain expansion during human evolution. J. Human Evol., 77: 88-98. DOI:10.1016/j.jhevol.2014.05.001
Das A, Srinivasan M, Ghosh T S, Mande S S. 2016. Xenobiotic metabolism and gut microbiomes. PLoS One, 11(10): e0163099.
Davenport E R, Sanders J G, Song S J, Amato K R, Clark A G, Knight R. 2017. The human microbiome in evolution. BMC Biol., 15: 127. DOI:10.1186/s12915-017-0454-7
De Clerck O, Bogaert K A, Leliaert F. 2012. Diversity and evolution of algae:primary endosymbiosis. Adv. Bot.Res., 64: 56-86.
De Jesus Raposo M F, De Morais A M M B, De Morais R M S C. 2016. Emergent sources of prebiotics:seaweeds and microalgae. Mar. Drugs, 14(2): 27. DOI:10.3390/md14020027
Den Besten G, Van Eunen K, Groen A K, Venema K, Reijngoud D J, Bakker B M. 2013. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res., 54(9): 2235-2340.
Devillé C, Gharbi M, Dandrifosse G, Peulen O. 2007. Study on the effects of laminarin, a polysaccharide from seaweed, on gut characteristics. J. Sci. Food Agric., 87(9): 1717-1725. DOI:10.1002/(ISSN)1097-0010
Dillehay T D, Ramírez C, Pino M, Collins M B, Rossen J, Pino-Navarro J D. 2008. Monte Verde:seaweed, food, medicine, and the peopling of South America. Science, 320(5877): 784-786. DOI:10.1126/science.1156533
Donia M S, Cimermancic P, Schulze C J, Brown L C W, Martin J, Mitreva M, Clardy J, Linington R G, Fischbach M A. 2014. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell, 158(6): 1402-1414. DOI:10.1016/j.cell.2014.08.032
Duncan S H, Lobley G E, Holtrop G, Ince J, Johnstone A M, Louis P, Flint H J. 2008. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes., 32(11): 1720-1724. DOI:10.1038/ijo.2008.155
El Kaoutari A, Armougom F, Gordon J I, Raoult D, Henrissat B. 2013. The abundance and variety of carbohydrateactive enzymes in the human gut microbiota. Nat. Rev.Microbiol., 11(7): 497-504. DOI:10.1038/nrmicro3050
Elson C O. 2000. Commensal bacteria as targets in Crohn's disease. Gastroenterology, 119(1): 254-257. DOI:10.1053/gast.2000.9159
Erny D, Hrabě De Angelis A L, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, Schwierzeck V, Utermöhlen O, Chun E, Garrett W S, McCoy K D, Diefenbach A, Staeheli P, Stecher B, Amit I, Prinz M. 2015. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci., 18(7): 965-977.
Farzi A, Fröhlich E E, Holzer P. 2018. Gut microbiota and the neuroendocrine system. Neurotherapeutics, 15(1): 5-22. DOI:10.1007/s13311-017-0600-5
Flórez L V, Biedermann P H W, Engl T, Kaltenpoth M. 2015. Defensive symbioses of animals with prokaryotic and eukaryotic microorganisms. Nat. Prod. Rep., 32(7): 904-936. DOI:10.1039/C5NP00010F
Garbary D J, London J F. 1995. The Ascophylluml Polysiphonial Mycosphaerella symbiosis V. Fungal infection protects A.nosodum from desiccation. Bot. Mar., 38(1-6): 529-533.
Gibson G R, Hutkins R, Sanders M E, Prescott S L, Reimer R A, Salminen S J, Scott K, Stanton C, Swanson K S, Cani P D, Verbeke K, Reid G. 2017. Expert consensus document:the international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev.Gastroenterol. Hepatol., 14(8): 491-502.
Gibson G R, Scott K P, Rastall R A, Tuohy K M, Hotchkiss A, Dubert-Ferrandon A, Gareau M G, Murphy E F, Saulnier D M, Loh G, Macfarlane S, Delzenne N, Ringel Y, Kozianowski G, Dickmann R, Lenoir-Wijnkoop I, Walker C, Buddington R K. 2010. Dietary prebiotics:current status and new definition. Food Sci. Technol. Bull.:Funct.Foods, 7(1): 1-19. DOI:10.1616/1476-2137.15880
Gibson G, Dworkin I. 2004. Uncovering cryptic genetic variation. Nat. Rev. Genet., 5(9): 681-690.
Global Burden of Disease Collaborators. 2017. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016:a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 390(10100): 1211-1259. DOI:10.1016/S0140-6736(17)32154-2
Goecke F, Labes A, Wiese J, Imhoff J F. 2010. Chemical interactions between marine macroalgae and bacteria. Mar. Ecol. Prog. Ser., 409: 267-300. DOI:10.3354/meps08607
Goraya J S, Kaur S, Mehra B. 2015. Neurology of nutritional vitamin B12 deficiency in infants:case series from India and literature review. J. Child. Neurol., 30(13): 1831-1837. DOI:10.1177/0883073815583688
Haygood R, Fedrigo O, Hanson B, Yokoyama K D, Wray G A. 2007. Promoter regions of many neural- and nutritionrelated genes have experienced positive selection during human evolution. Nat. Genet., 39(9): 1140-1144. DOI:10.1038/ng2104
Hehemann J H, Correc G, Barbeyron T, Helbert W, Czjzek M, Michel G. 2010. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature, 464(7290): 908-912. DOI:10.1038/nature08937
Hehemann J H, Kelly A G, Pudlo N A, Martens E C, Boraston A B. 2012. Bacteria of the human gut microbiome catabolize red seaweed glycans with carbohydrate-active enzyme updates from extrinsic microbes. Proc. Natl.Acad. Sci. U. S. A., 109(48): 19786-19791. DOI:10.1073/pnas.1211002109
Helliwell K E, Collins S, Kazamia E, Purton S, Wheeler G L, Smith A. 2015. Fundamental shift in vitamin B12 ecophysiology of a model alga demonstrated by experimental evolution. ISME J., 9(6): 1446-1455.
Holdt S L, Kraan S. 2011. Bioactive compounds in seaweed:functional food applications and legislation. J. Appl.Phycol., 23(3): 543-597. DOI:10.1007/s10811-010-9632-5
Holloway R L, Sherwood C C, Hof P R, Rilling J K. 2009.Evolution of the brain in humans-paleoneurology. In: Binder M D, Hirokawa N, Windhorst U eds. Encyclopedia of Neuroscience. Springer-Verlag, Berlin. p.1 326-1 334.
Hoyles L, Snelling T, Umlai U K, Nicholson J K, Carding S R, Glen R C, McArthur S. 2018. Microbiome-host systems interactions:protective effects of propionate upon the blood-brain barrier. Microbiome, 6: 55. DOI:10.1186/s40168-018-0439-y
Hutkins R W, Krumbeck J A, Bindels L B, Cani P D, Fahey G Jr, Goh Y J, Hamaker B, Martens E C, Mills D A, Rastal R A, Vaughan E, Sanders M E. 2016. Prebiotics:why definitions matter. Curr. Opin. Biotechnol., 37: 1-7. DOI:10.1016/j.copbio.2015.09.001
Ikeda S, Okubo T, Anda M, Nakashita H, Yasuda M, Sato S, Kaneko T, Tabata S, Eda S, Momiyama A, Terasawa K, Mitsui H, Minamisawa K. 2010. Community- and genome-based views of plant-associated bacteria:plantbacterial interactions in soybean and rice. Plant Cell Physiol., 51(9): 1398-1410. DOI:10.1093/pcp/pcq119
Jiménez-Escrig A, Gómez-Ordóñez E, Tenorio M D, Rupérez P. 2013. Antioxidant and prebiotic effects of dietary fiber co-travelers from sugar Kombu in healthy rats. J. Appl.Phycol., 25(2): 503-512.
Jocken J W E, González Hernández M A, Hoebers N T H, Van Der Beek C M, Essers Y P G, Blaak E E, Canfora E E. 2018. Short-chain fatty acids differentially affect intracellular lipolysis in a human white adipocyte model. Front. Endocrinol., 8: 372. DOI:10.3389/fendo.2017.00372
Jutur P P, Nesamma A A, Shaikh M R. 2016. Algae-derived marine oligosaccharides and their biological applications. Front. Mar. Sci., 3(39): 83.
Kadam S U, O'Donnell C P, Rai D K, Hossain M B, Burgess C M, Walsh D, Tiwari B K. 2015. Laminarin from Irish brown seaweeds Ascophyllum nodosum and Laminaria hyperborea:ultrasound assisted extraction, characterization and bioactivity. Mar. Drugs, 13(7): 4270-4280. DOI:10.3390/md13074270
Kausalya M, Narasimha Rao G M. 2015. Antimicrobial activity of marine algae. J. Algal Biomass Utln., 6(1): 78-87.
Kazamia E, Czesnick H, Van Nguyen T T, Croft M T, Sherwood E, Sasso S, Hodson S J, Warren M J, Smith A G. 2012. Mutualistic interactions between vitamin B12-dependent algae and heterotrophic bacteria exhibit regulation. Environ. Microbiol., 14(6): 1466-1476. DOI:10.1111/j.1462-2920.2012.02733.x
Kearney S M, Gibbons S M, Erdman S E, Alm E J. 2018.Orthogonal dietary niche enables reversible engraftment of a gut bacterial commensal. BioRxiv, 10.1101/275370
Kim J Y, Kwon Y M, Kim I S, Kim J A, Yu D Y, Adhikari B, Lee S S, Choi I S, Cho K K. 2018. Effects of the brown seaweed Laminaria japonica supplementation on serum concentrations of IgG, triglycerides, and cholesterol, and intestinal microbiota composition in rats. Front. Nutr., 5: 23. DOI:10.3389/fnut.2018.00023
Kim J Y, Yu D Y, Kim J A, Choi E Y, Lee C Y, Hong Y H, Kim C W, Lee S S, Choi I S, Cho K K. 2016. Effects of Undaria pinnatifida and Laminaria japonica on rat's intestinal microbiota and metabolite. J. Nutr. Food Sci., 6(3): 502. DOI:10.4172/2155-9600.1000502
Knoll A H. 2011. The multiple origins of complex multicellularity. Annu. Rev. Earth Planet. Sci., 39: 217-239. DOI:10.1146/
Kovatcheva-Datchary P, Nilsson A, Akrami R, Lee Y S, De Vadder F, Arora T, Hallen A, Martens E, Björck I, Bäckhed F. 2015. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab., 22(6): 971-982. DOI:10.1016/j.cmet.2015.10.001
Kulshreshtha G, Rathgeber B, Stratton G, Thomas N, Evans F, Critchley A, Hafting J, Prithiviraj B. 2014. Feed supplementation with red seaweeds, Chondrus crispus and Sarcodiotheca gaudichaudii, affects performance, egg quality, and gut microbiota of layer hens. Poult. Sci., 93(12): 2991-3001. DOI:10.3382/ps.2014-04200
Kyriacou K, Parkington J E, Marais A D, Braun D R. 2014. Nutrition, modernity and the archaeological record:coastal resources and nutrition among Middle Stone Age hunter-gatherers on the Western Cape coast of South Africa. J. Human Evol., 77: 64-73. DOI:10.1016/j.jhevol.2014.02.024
Lahaye M. 1991. Marine algae as sources of fibres:determination of soluble and insoluble dietary fibre contents in some 'sea vegetables'. J. Sci. Food Agric., 54(4): 587-594. DOI:10.1002/(ISSN)1097-0010
Le Chatelier E, Nielsen T, Qin J J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto J M, Kennedy S, Leonard P, Li J H, Burgdorf K, Grarup N, Jørgensen T, Brandslund I, Nielsen H B, Juncker A S, Bertalan M, Levenez F, Pons N, Rasmussen S, Sunagawa S, Tap J, Tims S, Zoetendal E G, Brunak S, Clément K, Doré J, Kleerebezem M, Kristiansen K, Renault P, SicheritzPonten T, De Vos W M, Zucker J D, Raes J, Hansen T, MetaHIT Consortium, Bork P, Wang J, Ehrlich S D, Pedersen O. 2013. Richness of human gut microbiome correlates with metabolic markers. Nature, 500(7464): 541-546. DOI:10.1038/nature12506
Leliaert F, Tronholm A, Lemieux C, Turmel M, DePriest M S, Bhattacharya D, Karol K G, Fredericq S, Zechman F W, Lopez-Bautista J M. 2016. Chloroplast phylogenomic analyses reveal the deepest-branching lineage of the Chlorophyta, Palmophyllophyceae class. nov. Sci. Rep., 6: 25. DOI:10.1038/srep25367
Ley R E, Bäckhed F, Turnbaugh P J, Lozupone C A, Knight R D, Gordon J I. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A., 102(31): 11070-11075. DOI:10.1073/pnas.0504978102
Ley R E, Hamady M, Lozupone C, Turnbaugh P J, Ramey R R, Bircher J S, Schlegel M L, Tucker T A, Schrenzel M D, Knight R, Gordon J I. 2008. Evolution of mammals and their gut microbes. Science, 320(5883): 1647-1651. DOI:10.1126/science.1155725
Ley R E, Turnbaugh P J, Klein S, Gordon J I. 2006. Microbial ecology:Human gut microbes associated with obesity. Nature, 444(7122): 1022-1023. DOI:10.1038/4441022a
Liu J H, Kandasamy S, Zhang J Z, Kirby C W, Karakach T, Hafting J, Critchley A T, Evans F, Prithiviraj B. 2015. Prebiotic effects of diet supplemented with the cultivated red seaweed Chondrus crispus or with fructo-oligosaccharide on host immunity, colonic microbiota and gut microbial metabolites. BMC Complement. Altern. Med., 15: 279. DOI:10.1186/s12906-015-0802-5
Lloyd-Price J, Abu-Ali G, Huttenhower C. 2016. The healthy human microbiome. Genome Med., 8(1): 51. DOI:10.1186/s13073-016-0307-y
Long S R. 2001. Genes and signals in the Rhizobium-legume symbiosis. Plant Physiol., 125(1): 69-72. DOI:10.1104/pp.125.1.69
MacFabe D. 2013. Autism:metabolism, mitochondria, and the microbiome. Global Adv. Health Med., 2(6): 52-66. DOI:10.7453/gahmj.2013.089
Margulis L. 1974. Origin and evolution of the eukaryotic cell. Taxono, 23(2-3): 225-226.
Margulis L. 1993. Symbiosis in Cell Evolution: Microbial Communities in the Archean and Proterozoic Eons. 2nd edn. Freeman, New York. 448p.
Marshall K, Joint I, Callow M E, Callow J A. 2006. Effect of marine bacterial isolates on the growth and morphology of axenic plantlets of the green alga Ulva linza. Microbial Ecol., 52(2): 302-310. DOI:10.1007/s00248-006-9060-x
Martens E C, Kelly A G, Tauzin A S, Brumer H. 2014. The devil lies in the details:how variations in polysaccharide fine-structure impact the physiology and evolution of gut microbes. J Mol. Biol., 426(23): 3851-3865. DOI:10.1016/j.jmb.2014.06.022
Mazmanian S K, Liu C H, Tzianabos A O, Kasper D L. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell, 122(1): 107-118. DOI:10.1016/j.cell.2005.05.007
Mazmanian S K, Round J L, Kasper D L. 2008. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature, 453(7195): 620-625. DOI:10.1038/nature07008
Miranda L N, Hutchison K, Grossman A R, Brawley S H. 2013. Diversity and abundance of the bacterial community of the red macroalga Porphyra umbilicalis:did bacterial farmers produce macroalgae?. PLoS One, 8(3): e58269. DOI:10.1371/journal.pone.0058269
Moeller A H, Caro-Quintero A, Mjungu D, Georgiev A V, Lonsdorf E V, Muller M N, Pusey A E, Peeters M, Hahn B H, Ochman H. 2016. Cospeciation of gut microbiota with hominids. Science, 353(6297): 380-382. DOI:10.1126/science.aaf3951
Moos W H, Faller D V, Harpp D N, Kanara I, Pernokas J, Powers W R, Steliou K. 2016. Microbiota and neurological disorders:a gut feeling. BioRes. Open Access, 5(1): 137-145. DOI:10.1089/biores.2016.0010
Mouritsen O G. 2013. Seaweeds:Edible, Available & Sustainable. University of Chicago Press, Chicago.
Moya-Pérez A, Luczynski P, Renes I B, Wang S G, Borre Y, Ryan C A, Knol J, Stanton C, Dinan T G, Cryan J F. 2017. Intervention strategies for cesarean section-induced alterations in the microbiota-gut-brain axis. Nutr. Rev., 75(4): 225-240. DOI:10.1093/nutrit/nuw069
Muegge B D. 2013. The Influence of Diet on the Mammalian Gut Microbiome. Washington University, St. Louis, Missouri.
Nanjundappa R H, Ronchi F, Wang J G, Clemente-Casares X, Yamanouchi J, Umeshappa C S, Yang Y, Blanco J, Bassolas-Molina H, Salas A, Khan H, Slattery R M, Wyss M, Mooser C, Macpherson A J, Sycuro L K, Serra P, McKay D M, McCoy K D, Santamaria P. 2017. A gut microbial mimic that hijacks diabetogenic autoreactivity to suppress colitis. Cell, 171(3): 655-667.
Nowack E C M, Weber A P M. 2018. Genomics-informed insights into endosymbiotic organelle evolution in photosynthetic eukaryotes. Annu. Rev. Plant Biol., 69: 51-84. DOI:10.1146/annurev-arplant-042817-040209
O'Doherty J V, Dillon S, Figat S, Callan J J, Sweeney T. 2010. The effects of lactose inclusion and seaweed extract derived from Laminaria spp. on performance, digestibility of diet components and microbial populations in newly weaned pigs. Anim. Feed Sci. Technol., 157(3-4): 173-180. DOI:10.1016/j.anifeedsci.2010.03.004
O'Hara A M, Shanahan F. 2006. The gut flora as a forgotten organ. EMBO Rep., 7(7): 688-693. DOI:10.1038/sj.embor.7400731
Okolie C L, Rajendran S R C K, Udenigwe C C, Aryee A N A, Mason B. 2017. Prospects of brown seaweed polysaccharides (BSP) as prebiotics and potential immunomodulators. J. Food Biochem., 41(5): e12392. DOI:10.1111/jfbc.12392
Oriach C S, Robertson R C, Stanton C, Cryan J F, Dinan T G. 2016. Food for thought:the role of nutrition in the microbiota-gut-brain axis. Clin. Nutr. Exp., 6: 25-38. DOI:10.1016/j.yclnex.2016.01.003
Pérez M J, Falqué E, Domínguez H. 2016. Antimicrobial action of compounds from marine seaweed. Mar. Drugs, 14(3): 52. DOI:10.3390/md14030052
Perry R J, Peng L, Barry N A, Cline G W, Zhang D Y, Cardone R L, Petersen K F, Kibbey R G, Goodman A L, Shulman G I. 2016. Acetate mediates a microbiome-brain-ǂ-cell axis to promote metabolic syndrome. Nature, 534(7606): 213-217.
Popper Z A, Michel G, Hervé C, Domozych D S, Willats W G T, Tuohy M G, Kloareg B, Stengel D B. 2011. Evolution and diversity of plant cell walls:from algae to flowering plants. Annu. Rev. Plant Biol., 62: 567-590. DOI:10.1146/annurev-arplant-042110-103809
Provasoli L, Pintner I J. 1980. Bacteria induced polymorphism in an axenic laboratory strain of Ulva lactuca(Chlorophyceae). J. Phycol., 16(2): 196-200. DOI:10.1111/jpy.1980.16.issue-2
Qin J J, Li R Q, Raes J, Arumugam M, Burgdorf K S, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende D R, Li J H, Xu J M, Li S C, Li D F, Cao J J, Wang B, Liang H Q, Zheng H S, Xie Y L, Tap J, Lepage P, Bertalan M, Batto J M, Hansen T, Le Paslier D, Linneberg A, Nielsen H B, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H M, Yu C, Li S T, Jian M, Zhou Y, Li Y R, Zhang X Q, Li S G, Qin N, Yang H M, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J; MetaHIT Consortium, Bork P, Ehrlich S D, Wang J. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 464(7285): 59-65. DOI:10.1038/nature08821
Rauma A L, Törrönen R, Hänninen O, Mykkänen H. 1995. Vitamin B-12 status of long-term adherents of a strict uncooked vegan diet ("living food diet") is compromised. J. Nutr., 125(10): 2511-2515.
Rebuffet E, Groisillier A, Thompson A, Jeudy A, Barbeyron T, Czjzek M, Michel G. 2011. Discovery and structural characterization of a novel glycosidase family of marine origin. Environ. Microbiol., 13(5): 1253-1270. DOI:10.1111/emi.2011.13.issue-5
Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, De Los Reyes-Gavilán C G, Salazar N. 2016. Intestinal short chain fatty acids and their link with diet and human health. Front. Microbiol., 7: 185. DOI:10.3389/fmicb.2016.00185
Riscuta G, Xi D, Pierre-Victor D, Starke-Reed P, Khalsa J, Duffy L. 2018. Diet, microbiome, and epigenetics in the era of precision medicine. In: Dumitrescu R G, Verma M eds. Cancer Epigenetics for Precision Medicine. Humana Press, New York, NY. p.141-156.
Roszyk E, Puszczewicz M. 2017. Role of human microbiome and selected bacterial infections in the pathogenesis of rheumatoid arthritis. Reumatologia, 55(5): 242-250.
Roumeliotis N, Dix D, Lipson A. 2012. Vitamin B12 deficiency in infants secondary to maternal causes. CMAJ, 184(14): 1593-1598. DOI:10.1503/cmaj.112170
Round J L, Mazmanian S K. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol., 9(5): 313-323. DOI:10.1038/nri2515
Salvia-Trujillo L, Sun Q, Um B H, Park Y, McClements D J. 2015. In vitro and in vivo study of fucoxanthin bioavailability from nanoemulsion-based delivery systems:impact of lipid carrier type. J. Func. Foods, 17: 293-304. DOI:10.1016/j.jff.2015.05.035
Sawicki C M, Livingston K A, Obin M, Roberts S B, Chung M, McKeown N M. 2017. Dietary fiber and the human gut microbiota:application of evidence mapping methodology. Nutrients, 9(2): 125. DOI:10.3390/nu9020125
Schoenemann P T. 2006. Evolution of the size and functional areas of the human brain. Annu. Rev. Anthropol., 35: 379-406. DOI:10.1146/annurev.anthro.35.081705.123210
Seetharam B, Alpers D H. 1982. Absorption and transport of cobalamin (vitamin B12). Annu. Rev. Nutr., 2: 343-369. DOI:10.1146/
Siavoshian S, Segain J P, Kornprobst M, Bonnet C, Cherbut C, Galmiche J P, Blottière H M. 2000. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells:induction of cyclin D3 and p21 expression. Gut, 46(4): 507-514.
Singh R P, Bijo A J, Baghel R S, Reddy C R K, Jha B. 2011. Role of bacterial isolates in enhancing the bud induction in the industrially important red alga Gracilaria dura. FEMS Microbiol. Ecol., 76(2): 381-392. DOI:10.1111/fem.2011.76.issue-2
Singh R P, Reddy C R K. 2014. Seaweed-microbial interactions:key functions of seaweed-associated bacteria. FEMS Microbiol. Ecol., 88(2): 213-230. DOI:10.1111/fem.2014.88.issue-2
Sonnenburg E D, Smits S A, Tikhonov M, Higginbottom S K, Wingreen N S, Sonnenburg J L. 2016. Diet-induced extinctions in the gut microbiota compound over generations. Nature, 529(7585): 212-215. DOI:10.1038/nature16504
Sonnenburg J L. 2010. Genetic pot luck. Nature, 464(7920): 837-838.
Stengel D B, Connan S, Popper Z A. 2011. Algal chemodiversity and bioactivity:sources of natural variability and implications for commercial application. Biotechnol.Adv., 29(5): 483-501. DOI:10.1016/j.biotechadv.2011.05.016
Stevens C E, Hume I D. 1998. Contributions of microbes in vertebrate gastrointestinal tract to production and conservation of nutrients. Physiol. Rev., 78(2): 393-427. DOI:10.1152/physrev.1998.78.2.393
Tattersall I. 2014. Diet as driver and constraint in human evolution. J. Human Evol., 77: 141-142. DOI:10.1016/j.jhevol.2014.10.004
The Human Microbiome Project Consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature, 486(7402): 207-214.
Thiba A, Umar C A, Myende S, Nweke E, Rumbold K, Candy G. 2017. Differences in microbiome in rat models of cardiovascular disease. S. Afr. J. Surg., 55(2): 71.
Thomas F, Hehemann J H, Rebuffet E, Czjzek M, Michel G. 2011. Environmental and gut Bacteroidetes:the food connection. Front. Microbiol., 2: 93. DOI:10.3389/fmicb.2011.00093
Tramontano M, Andrejev S, Pruteanu M, Klünemann M, Kuhn M, Galardini M, Jouhten P, Zelezniak A, Zeller G, Bork P, Typas A, Patil K R. 2018. Nutritional preferences of human gut bacteria reveal their metabolic idiosyncrasies. Nat. Microbiol., 3(4): 514-522. DOI:10.1038/s41564-018-0123-9
Verhaegen M, Munro S. 2011. Pachyosteosclerosis suggests archaic Homo frequently collected sessile littoral foods. HOMO, 62(4): 237-247. DOI:10.1016/j.jchb.2011.06.002
Vital M, Karch A, Pieper D H. 2017. Colonic butyrateproducing communities in humans:an overview using omics data. mSystems, 2(6): e00130-17. DOI:10.1128/msystems.00130-17
Von Schenck U, Bender-Götze C, Koletzko B. 1997. Persistence of neurological damage induced by dietary vitamin B-12 deficiency in infancy. Arch. Dis. Child., 77(2): 137-139. DOI:10.1136/adc.77.2.137
Wang M P, Chen L, Li YT, Chen L, Liu Z Y, Wang X J, Yan P S, Qin S. 2018a. Responses of soil microbial communities to a short-term application of seaweed fertilizer revealed by deep amplicon sequencing. Appl. Soil Ecol., 125: 288-296. DOI:10.1016/j.apsoil.2018.02.013
Wang S G, Harvey L, Martin R, Van Der Beek E M, Knol J, Cryan J, Renes I B. 2018b. Targeting the gut microbiota to influence brain development and function in early life. Neurosci. Biobehav. Rev., 95: 191-201. DOI:10.1016/j.neubiorev.2018.09.002
Wanyonyi S, Du Preez R, Brown L, Paul N A, Panchal S K. 2017. Kappaphycus alvarezii as a food supplement prevents diet-induced metabolic syndrome in rats. Nutrients, 9(11): 1261.
Watanabe F, Yabuta Y, Bito T, Teng F. 2014. Vitamin B12-containing plant food sources for vegetarians. Nutrients, 6(5): 1861-1873. DOI:10.3390/nu6051861
Wells M L, Potin P, Craigie J S, Raven J A, Merchant S S, Helliwell K E, Smith A G, Camire M E, Brawley S H. 2017. Algae as nutritional and functional food sources:revisiting our understanding. J. Appl. Phycol., 29(2): 949-982. DOI:10.1007/s10811-016-0974-5
West C E, Jenmalm M C, Prescott S L. 2015. The gut microbiota and its role in the development of allergic disease:a wider perspective. Clin. Exp. Allergy, 45(1): 43-53. DOI:10.1111/cea.2014.45.issue-1
WHO (World Health Organization). 2018. World Health Statistics 2018: Monitoring Health for the SDGs, Sustainable Development Goals.
Williams A G, Withers S, Sutherland A D. 2013. The potential of bacteria isolated from ruminal contents of seaweedeating North Ronaldsay sheep to hydrolyse seaweed components and produce methane by anaerobic digestion in vitro. Microb. Biotechnol., 6(1): 45-52. DOI:10.1111/1751-7915.12000
Woznica A, Gerdt J P, Hulett R E, Clardy J, King N. 2017. Mating in the closest living relatives of animals is induced by a bacterial chondroitinase. Cell, 170(6): 1175-1183. DOI:10.1016/j.cell.2017.08.005
Wu G D, Chen J, Hoffman C, Bittinger K, Chen Y Y, Keilbaugh S A, Bewtra M, Knights D, Walters W A, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H Z, Bushman F D, Lewis J D. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science, 334(6052): 105-108. DOI:10.1126/science.1208344
Xiong Y Q, Yang R, Sun X X, Yang H T, Chen H M. 2017. Effect of the epiphytic bacterium Bacillus sp. WPySW2 on the metabolism of Pyropia haitanensis. J. Appl.Phycol., 30(2): 1225-1237. DOI:10.1007/s10811-017-1279-z
You X M, Einson J E, Lopez-Pena C L, Song M Y, Xiao H, McClements D J, Sela D A. 2017. Food-grade cationic antimicrobial Dž-polylysine transiently alters the gut microbial community and predicted metagenome function in CD-1 mice. NPJ Sci. Food, 1: 8. DOI:10.1038/s41538-017-0006-0
Zhang Z S, Wang X M, Han S W, Liu C D, Liu F. 2018. Effect of two seaweed polysaccharides on intestinal microbiota in mice evaluated by illumina PE250 sequencing. Int. J.Biol. Macromol., 112: 796-802. DOI:10.1016/j.ijbiomac.2018.01.192
Zhou M, Hunerberg M, Chen Y H, Reuter T, McAllister T A, Evans F, Critchley A T, Guan L L. 2018. Air-dried brown seaweed, Ascophyllum nodosum, alters the rumen microbiome in a manner that changes rumen fermentation profiles and lowers the prevalence of foodborne pathogens. mSphere, 3(1): e00017-18. DOI:10.1128/mSphere.00017-18
Zilber-Rosenberg I, Rosenberg E. 2008. Role of microorganisms in the evolution of animals and plants:the hologenome theory of evolution. FEMS Microbiol. Rev., 32(5): 723-735. DOI:10.1111/j.1574-6976.2008.00123.x